Research team finds effective neutralizing antibodies against SARS-CoV2

Research team finds effective neutralizing antibodies against SARS-CoV2

A joint research team led by Sunney Xie, Director of the Beijing Advanced Innovation Center for Genomics (ICG) at Peking University (PKU) has successfully identified multiple highly potent neutralizing antibodies against the new CORONAvirus SARS-CoV-2, the cause respiratory tract virus COVID-19 disease, of convalescent plasma by sequencing of high-performance individual cells. Generated by the human immune system, neutralizing antibodies can effectively prevent viruses from infecting cells. New results from animal studies showed that its neutralizing antibody provides a potential cure for COVID-19, as well as means for short-term prevention. This marks an important milestone in the fight against the pandemic.

See full news – phys.org